These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24507753)

  • 41. CXCL16 haplotypes in patients with human carotid atherosclerosis: preliminary results.
    Zivković M; Djurić T; Stojković L; Jovanović I; Končar I; Davidović L; Veljković N; Alavantić D; Stanković A
    J Atheroscler Thromb; 2015; 22(1):10-20. PubMed ID: 25142184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
    Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE
    Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
    Lv Y; Hou X; Ti Y; Bu P
    Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.
    Gao Q; Zhao YJ; Wang XY; Qiu SJ; Shi YH; Sun J; Yi Y; Shi JY; Shi GM; Ding ZB; Xiao YS; Zhao ZH; Zhou J; He XH; Fan J
    Cancer Res; 2012 Jul; 72(14):3546-56. PubMed ID: 22710437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
    Huang Y; Zhang J; Cui ZM; Zhao J; Zheng Y
    Chin J Cancer; 2013 May; 32(5):289-96. PubMed ID: 22958742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells.
    Hanamoto H; Nakayama T; Miyazato H; Takegawa S; Hieshima K; Tatsumi Y; Kanamaru A; Yoshie O
    Am J Pathol; 2004 Mar; 164(3):997-1006. PubMed ID: 14982853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
    Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
    J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
    Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
    [No Abstract]   [Full Text] [Related]  

  • 49. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.
    Wang J; Lu Y; Wang J; Koch AE; Zhang J; Taichman RS
    Cancer Res; 2008 Dec; 68(24):10367-76. PubMed ID: 19074906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCR6: the role of environment in tumor progression. Challenges for therapy.
    La Porta CA
    Stem Cell Rev Rep; 2012 Dec; 8(4):1282-5. PubMed ID: 22678828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.
    Facco M; Baesso I; Miorin M; Bortoli M; Cabrelle A; Boscaro E; Gurrieri C; Trentin L; Zambello R; Calabrese F; Cassatella MA; Semenzato G; Agostini C
    J Leukoc Biol; 2007 Oct; 82(4):946-55. PubMed ID: 17615381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors.
    Abrahao-Machado LF; Antunes B; Filippi RZ; Volc S; Boldrini E; Menezes WP; Reis RM; de Camargo OP
    Biomark Med; 2018 Jan; 12(1):35-44. PubMed ID: 29243509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
    Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
    Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The CXCL16-CXCR6 chemokine axis in glial tumors.
    Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
    J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
    Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
    J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.
    Ludwig A; Schulte A; Schnack C; Hundhausen C; Reiss K; Brodway N; Held-Feindt J; Mentlein R
    J Neurochem; 2005 Jun; 93(5):1293-303. PubMed ID: 15934948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.
    Yildiz I; Sen F; Ekenel M; Darendeliler E; Bavbek S; Agaoglu F; Ozger H; Eralp L; Bilgic B; Basaran M
    In Vivo; 2014; 28(3):403-9. PubMed ID: 24815845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased expression of CXCL16, a bacterial scavenger receptor, in the colon of children with ulcerative colitis.
    Kalliomäki M; Rajala S; Elamo H; Ashorn M; Ruuska T
    J Crohns Colitis; 2014 Oct; 8(10):1222-6. PubMed ID: 24630488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
    Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
    J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.